An in-vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method

摘要

The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.